Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
190.00    3.00 (1.62%)
Bid:
185.00
Ask:
195.00
Spread: 10.00 (5.405%)
Market Cap: £99.47m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

AGM Statement

11 Jun 2018 07:00

RNS Number : 8613Q
Somero Enterprises Inc.
11 June 2018
 

11 June 2018

Somero Enterprises, Inc.

("Somero" or the "Company")

AGM Statement

Somero Enterprises, Inc. is pleased to provide an update on trading ahead of its Annual General Meeting to be held on Tuesday 12 June 2018.

Trading Update

Somero is pleased with the broad contributions to the Company's growth at this early stage of the year and the positive market conditions we continue to see across our portfolio of territories. North America and Europe remain healthy markets with robust activity levels and we remain encouraged by the performance in China in the period as we continue to work on gaining traction in this significant market. We are similarly encouraged by solid activity levels in the Middle East, Latin America and our Rest of World territories and we see opportunities for growth in each of these markets.

On a product basis we have seen balanced contributions from each product category as sales of Boomed screeds, Ride-on screeds and Parts and accessories have all been key contributors to growth to start the year.

The Company continues to focus heavily on future growth initiatives and product development efforts, and has progressed in developing a solution for concrete leveling in the structural high-rise market segment. Through job-site testing of our prototype machines we have gained valuable insight into the this market segment and identified opportunities to improve the design of the equipment that will increase the value of the offering. We are encouraged by the Company's progress in the long-term effort to penetrate a new market segment.

In summary, the Company feels comfortable with the positive trading environment across our footprint, and the growth opportunities visible in North America, Europe, China, Middle East, Latin America and our Rest of World territories. This constructive environment combined with solid margin performance and healthy operating cash flow generation means the Company's trading to date is ahead of the comparable prior year period and in-line with market expectations for the full year ending 31 December 2018.

Succession Planning

The Board has implemented a clear succession planning process to provide for the measured transition of responsibilities from President and Chief Executive Officer, Jack Cooney, to the current, experienced senior leadership team. The transition of responsibilities is designed to take place gradually over the next three years to ensure an orderly transition of his day-to-day responsibilities.

Mr. Cooney has been nominated for re-election to the Board of Directors, subject to shareholder approval at the Annual General Meeting on 12 June 2018, for a three-year term coinciding with the transition of his responsibilities as President and Chief Executive Officer. It is expected Mr. Cooney, after transition of his current executive responsibilities, will be considered by the Nominating Committee for re-election to the Board as a non-executive director.

The Board also has a succession planning process designed to provide for a highly independent, well-qualified Board, with the diversity, experience and background to be effective and to provide strong oversight. A key element to the Board succession planning process is the Board retirement policy adopted in November 2017. The Board retirement policy states directors shall not be re-nominated for election after reaching 75 years of age, provided that the Board may approve exceptions to the policy based on a recommendation from the Nominating Committee, and that if a director reaches the age of 75 during his or her term, the director will offer to resign in writing. The Board retirement policy further states the remaining members of the Board may choose to accept, defer or reject the offer to resign. Based on Mr. Cooney's current age of 71, this retirement policy is not applicable for the duration of his proposed new three-year term, as described above. The Board unanimously agreed to implement this policy in 2017 as an important mechanism to ensure orderly transition of responsibilities for directors that reach retirement age and to ensure the Board remains well-qualified and effective in its oversight role for the benefit of Somero and its shareholders.

The Annual General Meeting will be held via webcast and participation is encouraged by registering online at https://services.choruscall.com/links/som180612ngn5zGn5.html. This link can also be found on our website at https://investors.somero.com/.

For further information, please contact:

 

Somero Enterprises, Inc. www.somero.com

Jack Cooney, CEO +1 239 210 6500

John Yuncza, CFO

Howard Hohmann, EVP Sales

 

finnCap Ltd (NOMAD & Broker)

Matt Goode (Corporate Finance) +44 (0)20 7220 0500

Carl Holmes (Corporate Finance)

Tim Redfern (Corporate Broking)

 

Alma PR (Financial PR Advisor) somero@almapr.co.uk

Rebecca Sanders-Hewett +44 (0) 2038 659 667

Susie Hudson

Sam Modlin

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUROWRWVANAAR
Date   Source Headline
18th Dec 20147:00 amRNSAnnouncement re: new office in Shanghai, China
10th Dec 20144:03 pmRNSHolding(s) in Company
25th Nov 20147:00 amRNSDirector Appointments and trading update
17th Nov 20144:36 pmRNSTransaction in Restricted Stock Units
9th Oct 20147:00 amRNSChanges to the Company's Bylaws
6th Oct 20147:00 amRNSDirectorate Change
3rd Oct 20143:44 pmRNSHolding(s) in Company
3rd Oct 20147:00 amRNSDirector/PDMR Shareholding
2nd Oct 20144:22 pmRNSTransaction in Own Shares
16th Sep 20147:58 amRNSOption Buy-Back
8th Sep 20147:00 amRNSInterim Results
4th Sep 20145:27 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSTransaction in Own Shares
3rd Jul 20147:00 amRNSTrading Statement
16th Jun 20142:30 pmRNSTransaction in Own Shares
20th May 201412:04 pmRNSResult of AGM
19th May 20147:00 amRNSAGM Statement
1st May 20142:14 pmRNSAnnual Report and Notice of AGM
8th Apr 20147:00 amRNSFull year results for twelve months to 31/12/13
2nd Apr 20143:16 pmRNSHolding(s) in Company
11th Mar 20141:14 pmRNSHolding(s) in Company
5th Feb 20145:45 pmRNSDirector/PDMR Shareholding
30th Jan 20144:50 pmRNSDirector/PDMR Shareholding
14th Jan 20147:00 amRNSTrading Update
20th Dec 201312:36 pmRNSHolding(s) in Company
12th Dec 20132:45 pmRNSHolding(s) in Company
5th Dec 20134:07 pmRNSHolding(s) in Company
21st Nov 20132:31 pmRNSOption Buy-Back
15th Nov 20137:55 amRNSOption Buy-Back
30th Oct 20133:28 pmRNSDirector/PDMR Shareholding
28th Oct 20131:55 pmRNSHolding(s) in Company
18th Oct 20135:03 pmRNSHolding(s) in Company
17th Oct 20134:45 pmRNSHolding(s) in Company
8th Oct 20137:00 amRNSTrading Update
3rd Sep 20137:00 amRNSInterim Results
2nd Jul 20137:00 amRNSDirector/PDMR Shareholding
27th Jun 20137:42 amRNSDirector/PDMR Shareholding
26th Jun 20137:00 amRNSTransaction in Own Shares
19th Jun 20134:45 pmRNSDirector/PDMR Shareholding
13th Jun 20137:00 amRNSTrading Statement
20th May 20137:00 amRNSTransaction in Own Shares
30th Apr 20133:03 pmRNSResult of AGM
30th Apr 20137:00 amRNSAGM Statement
23rd Apr 201311:44 amRNSHolding(s) in Company
19th Apr 20134:46 pmRNSHolding(s) in Company
21st Mar 20137:00 amRNSDirector/PDMR Shareholding
20th Mar 20139:17 amRNSChange of Adviser
13th Mar 20137:00 amRNSAnnual Report and Notice of AGM
26th Feb 20137:00 amRNSFinal Results
3rd Jan 20134:06 pmRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.